483 related articles for article (PubMed ID: 23313283)
1. Disruption of aldehyde dehydrogenase 2 gene results in altered cortical bone structure and increased cortical bone mineral density in the femoral diaphysis of mice.
Tsuchiya T; Sakai A; Menuki K; Mori T; Takeuchi Y; Kanoh S; Utsunomiya H; Murai T; Isse T; Kawamoto T; Nakamura T
Bone; 2013 Apr; 53(2):358-68. PubMed ID: 23313283
[TBL] [Abstract][Full Text] [Related]
2. Cortical bone loss due to skeletal unloading in aldehyde dehydrogenase 2 gene knockout mice is associated with decreased PTH receptor expression in osteocytes.
Tajima T; Menuki K; Okuma KF; Tsukamoto M; Fukuda H; Okada Y; Kosugi K; Yamanaka Y; Uchida S; Sakai A
Bone; 2018 May; 110():254-266. PubMed ID: 29482068
[TBL] [Abstract][Full Text] [Related]
3. Reduced bone formation in alcohol-induced osteopenia is associated with elevated p21 expression in bone marrow cells in aldehyde dehydrogenase 2-disrupted mice.
Shimizu Y; Sakai A; Menuki K; Mori T; Isse T; Oyama T; Kawamoto T; Nakamura T
Bone; 2011 May; 48(5):1075-86. PubMed ID: 21256255
[TBL] [Abstract][Full Text] [Related]
4. Disruption of the Aldehyde Dehydrogenase 2 Gene Results in No Increase in Trabecular Bone Mass Due to Skeletal Loading in Association with Impaired Cell Cycle Regulation Through p21 Expression in the Bone Marrow Cells of Mice.
Okuma KF; Menuki K; Tsukamoto M; Tajima T; Fukuda H; Okada Y; Mori T; Tsuchiya T; Kawamoto T; Yoshida Y; Uchida S; Sakai A
Calcif Tissue Int; 2017 Sep; 101(3):328-340. PubMed ID: 28474171
[TBL] [Abstract][Full Text] [Related]
5. Chronic alcohol consumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength.
Wezeman FH; Emanuele MA; Emanuele NV; Moskal SF; Woods M; Suri M; Steiner J; LaPaglia N
Alcohol Clin Exp Res; 1999 Sep; 23(9):1534-42. PubMed ID: 10512321
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-specific targeting of soluble colony-stimulating factor-1 increases cortical bone thickness in mice.
Abboud SL; Ghosh-Choudhury N; Liu LC; Shen V; Woodruff K
J Bone Miner Res; 2003 Aug; 18(8):1386-94. PubMed ID: 12929928
[TBL] [Abstract][Full Text] [Related]
7. Mineral density and bone strength are dissociated in long bones of rat osteopetrotic mutations.
Tuukkanen J; Koivukangas A; Jämsä T; Sundquist K; Mackay CA; Marks SC
J Bone Miner Res; 2000 Oct; 15(10):1905-11. PubMed ID: 11028442
[TBL] [Abstract][Full Text] [Related]
8. Aldehyde-stress resulting from Aldh2 mutation promotes osteoporosis due to impaired osteoblastogenesis.
Hoshi H; Hao W; Fujita Y; Funayama A; Miyauchi Y; Hashimoto K; Miyamoto K; Iwasaki R; Sato Y; Kobayashi T; Miyamoto H; Yoshida S; Mori T; Kanagawa H; Katsuyama E; Fujie A; Kitagawa K; Nakayama KI; Kawamoto T; Sano M; Fukuda K; Ohsawa I; Ohta S; Morioka H; Matsumoto M; Chiba K; Toyama Y; Miyamoto T
J Bone Miner Res; 2012 Sep; 27(9):2015-23. PubMed ID: 22508505
[TBL] [Abstract][Full Text] [Related]
9. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of retinaldehyde dehydrogenase 1 induces BMP2 and increases bone mass in vivo.
Nallamshetty S; Wang H; Rhee EJ; Kiefer FW; Brown JD; Lotinun S; Le P; Baron R; Rosen CJ; Plutzky J
PLoS One; 2013; 8(8):e71307. PubMed ID: 23951127
[TBL] [Abstract][Full Text] [Related]
11. Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model.
Kosugi K; Tajima T; Menuki K; Okuma KF; Tokuda K; Fukuda H; Okada Y; Tsukamoto M; Yamanaka Y; Zenke Y; Sakai A
Bone; 2020 Jul; 136():115370. PubMed ID: 32325250
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.
Le PT; Bishop KA; Maridas DE; Motyl KJ; Brooks DJ; Nagano K; Baron R; Bouxsein ML; Rosen CJ
Bone; 2017 Dec; 105():103-114. PubMed ID: 28821457
[TBL] [Abstract][Full Text] [Related]
13. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
[TBL] [Abstract][Full Text] [Related]
14. Gender specific LRP5 influences on trabecular bone structure and strength.
Dubrow SA; Hruby PM; Akhter MP
J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087
[TBL] [Abstract][Full Text] [Related]
15. Climbing exercise increases bone mass and trabecular bone turnover through transient regulation of marrow osteogenic and osteoclastogenic potentials in mice.
Mori T; Okimoto N; Sakai A; Okazaki Y; Nakura N; Notomi T; Nakamura T
J Bone Miner Res; 2003 Nov; 18(11):2002-9. PubMed ID: 14606513
[TBL] [Abstract][Full Text] [Related]
16. X-ray imaging characterization of femoral bones in aging mice with osteopetrotic disorder.
Tu SJ; Huang HW; Chang WJ
Micron; 2015 Apr; 71():14-21. PubMed ID: 25614341
[TBL] [Abstract][Full Text] [Related]
17. Surface-specific effects of a PPARgamma agonist, darglitazone, on bone in mice.
Li M; Pan LC; Simmons HA; Li Y; Healy DR; Robinson BS; Ke HZ; Brown TA
Bone; 2006 Oct; 39(4):796-806. PubMed ID: 16759917
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats.
Kodama Y; Nakayama K; Fuse H; Fukumoto S; Kawahara H; Takahashi H; Kurokawa T; Sekiguchi C; Nakamura T; Matsumoto T
J Bone Miner Res; 1997 Jul; 12(7):1058-67. PubMed ID: 9200005
[TBL] [Abstract][Full Text] [Related]
19. Morphological profile of atypical femoral fractures: age-related changes to the cross-sectional geometry of the diaphysis.
Imamura T; Tsurumoto T; Saiki K; Nishi K; Okamoto K; Manabe Y; Oyamada J; Ogami-Takamura K
J Anat; 2019 Nov; 235(5):892-902. PubMed ID: 31355449
[TBL] [Abstract][Full Text] [Related]
20. Congenic mice with low serum IGF-I have increased body fat, reduced bone mineral density, and an altered osteoblast differentiation program.
Rosen CJ; Ackert-Bicknell CL; Adamo ML; Shultz KL; Rubin J; Donahue LR; Horton LG; Delahunty KM; Beamer WG; Sipos J; Clemmons D; Nelson T; Bouxsein ML; Horowitz M
Bone; 2004 Nov; 35(5):1046-58. PubMed ID: 15542029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
